Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| 1,25-Dihydroxyvitamin D3 and the skin: a unique application for the treatment of psoriasis. | Academic Article |
Why?
|
| 1,25-Dihydroxyvitamin D3 for the treatment of psoriasis. | Academic Article |
Why?
|
| 1a,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. | Academic Article |
Why?
|
| A case of psoriasis accompanied by arthritis after delivery. | Academic Article |
Why?
|
| Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial. | Academic Article |
Why?
|
| Alcohol intake and risk of incident psoriasis in US women: a prospective study. | Academic Article |
Why?
|
| Analysis of expression pattern of serum microRNA levels in patients with psoriasis. | Academic Article |
Why?
|
| Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. | Academic Article |
Why?
|
| Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. | Academic Article |
Why?
|
| Association between pediatric psoriasis and the metabolic syndrome. | Academic Article |
Why?
|
| Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis. | Academic Article |
Why?
|
| Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States. | Academic Article |
Why?
|
| Circulating microRNA associated with TNF-a signaling pathway in patients with plaque psoriasis. | Academic Article |
Why?
|
| Complete primary treatment failure of adalimumab in a patient with photoaggravated psoriasis. | Academic Article |
Why?
|
| Current treatment options in psoriasis. | Academic Article |
Why?
|